Try our mobile app
Screener

Reviews

2025-05-17
#dividend #CSCO

Cisco will pay dividends in the amount of 0.41 USD per share on 2025-07-02, which is 0.6% of the current price 63.62. Together with previous payments, the annual dividend yield will be 2.5%

(2025-04-02: 0.41 USD)
(2025-01-02: 0.4 USD)
(2024-10-01: 0.4 USD)
2025-05-17
#dividend #BABA

Alibaba will pay dividends in the amount of 1.98 USD per share on 2025-06-11, which is 1.6% of the current price 123.46.
2025-05-17
#dividend #SBLK

Star Bulk Carriers will pay dividends in the amount of 0.05 USD per share on 2025-06-05, which is 0.3% of the current price 16.4. Together with previous payments, the annual dividend yield will be 8.8%

(2025-03-03: 0.09 USD)
(2024-12-04: 0.6 USD)
(2024-08-26: 0.7 USD)
2025-05-16
#reports #UTMD

[Utah Medical Products](https://eninvs.com/all.php?name=UTMD) (Medical Instruments and Supplies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186229)
(2025-01-28, Before Market Open):

- Revenue -9.1% YoY (vs -25.0% in previous quarter and historical rate +3.0%)
- EBITDA -20% YoY (vs 0.0% in previous quarter and historical rate -4.2%)
- EBITDA margin 40.0% decreased compared to 45.5% same period last year
- Net Debt decreased by $300 mln over the past reporting period (150.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 151.3% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 12.8x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +1.4% vs S&P500 +0.5%
2025-05-16
#reports #SRTS

[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186124)
(2025-05-15, After Market Close):

- Revenue -27.3% YoY (vs 0.0% in previous quarter and historical rate +32.0%)
- EBITDA -200% YoY (vs -80.0% in previous quarter)
- EBITDA margin -37.5% decreased compared to 27.3% same period last year
- Net Debt decreased by $18 mln over the past reporting period (23.5% of market cap)
- FCF (LTM) +$0 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 18.3x compared to historical level (75th percentile) of 8.6x
- EV/Sales multiple is 1.5x

At the opening of the session the share price went down -4.7% vs S&P500 +0.2%
2025-05-16
#reports #RHE

[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186128)
(2025-04-03, After Market Close):

- Revenue +75% YoY (vs +20.0% in previous quarter and historical rate +6.8%)
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 1.7x

2025-05-16
#reports #POLA

[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186170)
(2024-11-15, After Market Close):

- Revenue 0% YoY (vs -25.0% in previous quarter and historical rate +8.2%)
- EBITDA margin -50.0% increased compared to -100.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (21.2% of market cap)
- FCF (LTM) +$0 bln (positive), 21.2% of market cap
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +599.7% vs S&P500 +0.2%
2025-05-16
#reports #NEPH

[Nephros](https://eninvs.com/all.php?name=NEPH) (Medical Instruments and Supplies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186139)
(2025-05-08, Before Market Open):

- Revenue +25% YoY (vs +33.3% in previous quarter and historical rate +25.0%)
- EBITDA margin 20.0% increased compared to 0.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 4.4% of market cap
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 18x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went up +0.5% vs S&P500 +0.6%
2025-05-16
#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186140)
(2022-11-17):

- Revenue -66.7% YoY (vs -66.7% in previous quarter and historical rate +88.9%)
- EBITDA margin -100.0% decreased compared to -33.3% same period last year
- Net Debt decreased by $3 mln over the past reporting period (72.0% of market cap)
- FCF (LTM) -$0 bln (negative), 72.0% of market cap
- EV/Sales multiple is 0.2x

2025-05-16
#reports #MITQ

[Moving iMage Technologies, Inc.](https://eninvs.com/all.php?name=MITQ) (Communication Equipment) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186191)
(2023-02-14, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +23.5%)
- EV/EBITDA multiple is 1.8x compared to historical level (75th percentile) of 7x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +6.3%
2025-05-16
#reports #GTEC

[Greenland Technologies Corporation](https://eninvs.com/all.php?name=GTEC) (Specialty Industrial Machinery) reported for 2025 q1
(2025-05-15, After Market Close):

- Revenue -4.3% YoY (vs -17.4% in previous quarter and historical rate -10.7%)
- EBITDA +150% YoY (vs +33.3% in previous quarter and historical rate +17.6%)
- EBITDA margin 22.7% increased compared to 8.7% same period last year
- Net Debt increased by $6 mln over the past reporting period (18.5% of market cap)
- FCF (LTM) +$0 bln (positive), 61.6% of market cap
- EV/EBITDA multiple is 0.4x compared to historical level (75th percentile) of 1.6x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -1.5% vs S&P500 +0.2%
2025-05-16
#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186154):

- Revenue 0% YoY (vs -25.0% in previous quarter and historical rate -0.5%)
- EBITDA margin 92.3% increased compared to -15.4% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 13.1% of market cap
- EV/Sales multiple is 2.2x

2025-05-16
#reports #DOCS

[Doximity, Inc.](https://eninvs.com/all.php?name=DOCS) (Health Information Services) reported for 2025 q1
(2025-05-15, After Market Close):

- Revenue +16.9% YoY (vs +25.2% in previous quarter and historical rate +18.6%)
- EBITDA +18.2% YoY (vs +36.1% in previous quarter and historical rate +27.3%)
- EBITDA margin 37.7% increased compared to 37.3% same period last year
- Net Debt decreased by $71 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 41.8x compared to historical level (75th percentile) of 45x
- EV/Sales multiple is 17.6x

2025-05-16
#reports #CLRO

[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186235)
(2025-05-27, Before Market Open):

- Revenue -50% YoY (vs -25.0% in previous quarter and historical rate -28.3%)
- EBITDA margin -150.0% decreased compared to -50.0% same period last year
- EV/Sales multiple is 1.2x

2025-05-16
#reports #BFRI

[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186214)
(2023-08-11, Before Market Open):

- Revenue +12.5% YoY (vs +8.8% in previous quarter and historical rate +32.6%)
- EBITDA margin -55.6% increased compared to -62.5% same period last year
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -1.9%
2025-05-16
#reports #TTWO
@ gaming

[Take-Two Interactive Software](https://eninvs.com/all.php?name=TTWO) (Game developer) reported for 2025 q1
(2025-05-15, After Market Close):

- Revenue +13.2% YoY (vs -0.4% in previous quarter and historical rate +19.5%)
- EBITDA margin -228.9% decreased compared to -183.8% same period last year
- Net Debt decreased by $254 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.3% of market cap
- EV/Sales multiple is 7.4x

At the opening of the session the share price went up +1.8% vs S&P500 +0.2%
2025-05-16
#reports #NTES
@ china

[NetEase](https://eninvs.com/all.php?name=NTES) (IT services and products provider) reported for 2025 q1
(2025-05-15, Before Market Open):

- Revenue +6.8% YoY (vs -4.2% in previous quarter and historical rate +4.1%)
- EBITDA +32.7% YoY (vs +10.1% in previous quarter and historical rate +15.1%)
- EBITDA margin 37.9% increased compared to 30.5% same period last year
- Net Debt decreased by $747 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$2.7 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 4.3x

At the opening of the session the share price went up +8.2% vs S&P500 -0.4%
2025-05-16
#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186099)
(2025-05-16, Before Market Open):

- Revenue +43% YoY (vs -21.3% in previous quarter and historical rate +134.2%)
- EBITDA margin -2142.3% increased compared to -4721.5% same period last year
- Net Debt increased by $2.1 bln since the start of the year (5449.6% of market cap)
- FCF (LTM) -$10.8 bln (negative), 27548.7% of market cap
- EV/Sales multiple is 2.8x

2025-05-16
#reports #BEEM
@ renewable-energy

[Beam Global](https://eninvs.com/all.php?name=BEEM) (Solar) reported for 2025 q1
(2025-04-11, After Market Close):

- Revenue -60% YoY (vs -60.0% in previous quarter and historical rate +82.7%)
- EBITDA margin -233.3% decreased compared to -13.3% same period last year
- Net Debt increased by $2 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) +$0 bln (positive), 3.5% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +11.4% vs S&P500 +1.5%
2025-05-16
#reports #BABA
@ china , @ e-commerce

[Alibaba](https://eninvs.com/all.php?name=BABA) (Chinese e-commerce giant) reported for 2025 q1
(2025-05-15, Before Market Open):

- Revenue +6% YoY (vs +4.7% in previous quarter and historical rate +1.4%)
- EBITDA +56.5% YoY (vs +49.0% in previous quarter and historical rate +23.7%)
- EBITDA margin 15.9% increased compared to 10.8% same period last year
- Net Debt increased by $1.4 bln since the start of the year (0.4% of market cap)
- FCF (LTM) -$15.9 bln (negative), 4.9% of market cap
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 11.9x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went down -5.8% vs S&P500 -0.4%
2025-05-16
#dividend #BGS

B&G Foods will pay dividends in the amount of 0.19 USD per share on 2025-06-27, which is 4.3% of the current price 4.46. Together with previous payments, the annual dividend yield will be 17.0%

(2025-03-28: 0.19 USD)
(2024-12-30: 0.19 USD)
(2024-09-27: 0.19 USD)